Thyronin treatment in adult and pediatric heart surgery: Clinical experience and review of the literature

European Journal of Heart Failure

Volumn 4, Issue 5, 2002, Pages 577-582

  Carrel, Thierry ^a   Eckstein, Friedrich ^a   Englberger, Lars ^a   Mury, Raymond ^a   Mohacsi, Paul ^a  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Heart surgery; Hemodynamics; Hyronin; Transplantation

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; LIOTHYRONINE; METHYLPREDNISOLONE SODIUM SUCCINATE; MILRINONE; NITRIC OXIDE; NORADRENALIN; THYROID HORMONE; THYRONINE;

ADRENERGIC SYSTEM; BOLUS INJECTION; CHRONOTROPISM; CONGENITAL HEART MALFORMATION; CONTINUOUS INFUSION; ENERGY METABOLISM; HEART FAILURE; HEART MUSCLE REVASCULARIZATION; HEART OUTPUT; HEART SURGERY; HEART TRANSPLANTATION; HEART WORK; HEMODYNAMICS; HORMONE ACTION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; INOTROPISM; MEDICAL LITERATURE; PEDIATRIC SURGERY; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; REVIEW;

ADOLESCENT; ADULT; CARDIAC SURGICAL PROCEDURES; CHILD; HEART FAILURE, CONGESTIVE; HUMANS; SWITZERLAND; THYRONINES;

EID: 0036802204     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(02)00096-X     Document Type: Review

References (38)

1. Dillmann WH. Biochemical basis of thyroid hormone action in the heart. Am J Med 1990;88:626-30.
2. Brent FA. The molecular basis of thyroid hormone action. N Engl J Med 1994;331:847-53.
3. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system: From theory to practice. J Clin Endocrinol Metab 1994;78:1026-7.
4. Davis PJ, Davis FB. Acute cellular actions of thyroid hormone and myocardial function. Ann Thorac Surg 1993;56:S16-S23.
5. Walker JD, Crawford FA, Mukherjee R, et al. Direct effects of acute administration of 3,5,3′-triiodo-1-thyronine on myocyte function. Ann Thorac Surg 1994;58:851-6.
6. Polikar R, Burger AG, Scherrer U, et al. The thyroid and the heart. Circulation 1993;87:1435-41.
7. Morkin E, Flink IL, Goldman S. Biochemical and physiological effects of thyroid hormone on cardiac performance. Prog Cardiovasc Dis 1983;25:435-40.
8. Walker JD, Crawford FA, Muhkerjee R, et al. The direct effects of 3,5,3′-triiodothyronine on myocyte contractile process: Insights into mechanisms of action. J Thorac Cardiovasc Surg 1995;110:1369-80.
9. Okamaa K, Balkman C, Klein I. Acute effects of triiodothyronine on arterial smooth muscle cells. Ann Thorac Surg 1993;56:S61-S67.
10. Levey GS, Klein I. Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism. Am J Med 1990;88:642-6.
11. Dyke C. Thyroid hormone supplementation in coronary surgery. Ann Cardiac Surg 1997;10:1-7.
12. Utiger RD. Altered thyroid function in non-thyroid illness and surgery. To treat or not to treat? N Engl J Med 1995;333:1562-3.
13. Williams LT, Lefkowitz RJ, Watanabe AM, et al. Thyroid hormone regulation of beta-adrenergic receptor number. J Biol Chem 1977;252:2787-91.
14. Klemperer JD, Zelano J, Helm RE. Triiodothyronine improves left ventricular function without oxygen wasting effects after global hypothermic ischemia. J Thorac Cardiovasc Surg 1995;109:457-65.
15. Wartofsky L, Buman KD. Alterations in thyroid function in patients with systemic illness: The 'euthyroid sick syndrome'. Endocr Rev 1982;3:163-217.
16. 3) in low cardiac output following cardioplegic arrest and cardiopulmonary bypass: An initial experience in patients undergoing open heart surgery. Eur J Cardiothorac Surg 1989;3:140-5.
17. Klemperer JD, Klein I, Gomez M, et al. Thyroid hormone treatment after coronary artery bypass surgery. N Engl J Med 1995;333:1522-7.
18. Bjoem-Hansen LS, Weeke J. Changes in plasma free thyroid hormones during cardiopulmonary bypass do not indicate triiodothyronine substitution. J Thorac Cardiovasc Surg 1992;104:272-7.
19. Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311:819-23.
20. Hamilton M, Stevenson LV, Fonarow GC, et al. Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure. Am J Cardiol 1998;81:443-8.
21. Hamilton M, Stevenson LV, Luu M, et al. Abnormal triiodothyronine is the strongest short-term prognostic factor identified in advanced heart failure. J Am Coll Cardiol 1990;65:1209-12.
22. 3) and cardiovascular therapeutics: A review. J Cardiac Surg 1992;7:363-74.
23. Hamilton M. Prevalence and clinical implications of abnormal thyroid hormone metabolism in advanced heart failure. Ann Thorac Surg 1993;56:S48-S53.
24. Salter DR, Dyke CM. Cardiopulmonary dysfunction after brain death. Anesthesia for Organ Transplantation. Philadelphia: JB Lippincott, 1992. p. 8-94.
25. Novitzky D, Wicomb WN, Cooper DK, et al. Evidence of myocardial and renal functional recovery following hormonal treatment after brain death. Transplant Proc 1986;18:613-6.
26. Novitzky D, Cooper DK, Chaffin JS, et al. Improved cardiac allograft function following triiodothyronine therapy to both donor and recipient. Transplantation 1990;49:311-6.
27. Jeevanandam V, Todd B, Regillo T, et al. Reversal of donor myocardial dysfunction by triiodothyronine replacement therapy. J Heart Lung Transplant 1994;13:681-7.
28. Mitchell IM, Pollock JC, Jamieson MP, et al. The effects of cardiopulmonary bypass on thyroid function in infants weighing less than five kilograms. J Thorac Cardiovasc Surg 1992;103:800-5.
29. Clark R. Cardiopulmonary bypass and thyroid metabolism. Ann Thorac Surg 1993;56:S35-S42.
30. 4 syndrome with blunted thyrotropin response to thyrotropic releasing hormone. Hormone Res 1986;23:151-8.
31. Wechsler AS, Kadletz M, Ding M, et al. Effects of triiodothyronine on stunned myocardium. J Cardiac Surg 1993;8:338-41.
32. Novitzky D, Human PA, Cooper DK. Inotropic effects of triiodothyronine following myocardial ischemia and cardiopulmonary bypass: An experimental study in the pig. Ann Thorac Surg 1988;45:50-5.
33. Holland FW, Brown PS, Clark RE. Severe postischemic myocardial depression reversed by triiodothyronine. Ann Thorac Surg 1992;54:301-5.
34. Klemperer JD, Klein IL, Ojamaa K, et al. Triiodothyronine therapy lowers the incidence of atrial fibrillation after cardiac operations. Ann Thorac Surg 1996;61:1323-9.
35. Bennett-Guerrero E, Jimenez JL, White W, et al. Cardiovascular effects of intravenous triiodothyronine in patients undergoing coronary artery bypass graft surgery: A randomized, doubleblind placebo-controlled trial. J Am Med Assoc 1996;275:687-92.
36. Meldrum DR, Cleveland JC, Sheridan BC, et al. Cardiac surgical implications of calcium dyshomeostasis in the heart. Ann Thorac Surg 1996;61:1273-80.
37. Portman MA, Fearneyhough C, Ning XH, Duncan BW, Rosenthal GL, Lupinetti FM. Triiodothyronine repletion in infants during cardiopulmonary bypass for congenital heart disease. J Thorac Cardiovasc Surg 2000;120:604-8.
38. 3) treatment improves postoperative management in pediatric patients undergoing cardiac surgery. Circulation 2000;102(Suppl II):II-469.